Global private equity fund Advent International on Monday said it will be acquiring a controlling stake in pharma sector-focused Avra Laboratories, in a deal which values the company promoted by A V Rama Rao at USD 100 million.The 26-year-old Avra is headquartered in Hyderabad and engaged in contract manufacturing and research services and speciality active pharmaceutical ingredients.